
News|Articles|February 1, 2004
Extended-release formulation of oxymorphone effective for pain relief in osteoarthritis
The opioid oxymorphone (Numorphan, Endo) delivered in a new extended-release (ER) formulation significantly improves standard measures of pain and physical function in osteoarthritis (OA) patients, researchers reported at the American College of Rheumatology 67th Annual Scientific Meeting.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
ICER Analysis Finds Net Prices of New Drugs Rose 51% Over Three Years
2
People With Multiple Sclerosis Have Distinct Oral Microbiome, Study Shows
3
Digital Tool Helps More Adults Get Screened for Lung Cancer
4
Key Efficacy and Safety Data from the EMERALD Trial
5